Clinical trials
Phase 4 Panic Disorder trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 4 |
| 2008 | 3 |
| 2010 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Terminated | 4 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 4 |
| Massachusetts General Hospital | 3 |
| Indiana University | 2 |
| Maastricht University Medical Center | 2 |
| Samsung Medical Center | 2 |
| University of South Florida | 2 |
| Creighton University | 1 |
| Georgetown University | 1 |
| Hamilton Health Sciences Corporation | 1 |
| Inje University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Panic Disorder | 32 |
| Anxiety Disorders | 13 |
| Generalized Anxiety Disorder | 11 |
| Phobia, Social | 5 |
| Agoraphobia | 4 |
| Bipolar Disorder | 3 |
| Chest Pain | 2 |
| Dysthymic Disorder | 2 |
| Major Depressive Disorder | 2 |
| Obsessive-Compulsive Disorder | 2 |
Trials
Showing 51 to 32 of 32. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.